Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 2/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 10/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2796794 | 0.86 | RECQL (0.46) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL2796075 | 0.84 | RECQL (0.47) | RECQLGLAHPGDTSHRMAPK1 | |
| Bromide SCHEMBL2291326 | 0.84 | MEN1 (0.36) | MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| SCHEMBL2293237 | 0.80 | MEN1 (0.33) | MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Bromide SCHEMBL2289755 | 0.79 | MEN1 (0.34) | MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| SCHEMBL2290460 | 0.78 | RECQL (0.40) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL2859398 | 0.78 | RECQL (0.55) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL4407977 | 0.78 | RECQL (0.55) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL4415795 | 0.77 | RECQL (0.54) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL4410517 | 0.77 | RECQL (0.54) | RECQLGLAHPGDTSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2183220-B1 | BIODEGRADABLE SOLVENTS FOR THE CHEMICAL INDUSTRY | UNIV DUBLIN CITY (IE) | 2016-11-09 | — | — | EP | disclosed |
| US-8541598-B2 | Biodegradable solvents for the chemical industry | DUBLIN CITY UNIVERSITY (IE) | 2013-09-24 | — | — | US | disclosed |
| US-20110201824-A1 | BIODEGRADABLE SOLVENTS FOR THE CHEMICAL INDUSTRY | DUBLIN CITY UNIVERSITY (IE) | 2011-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201824-A1 | BIODEGRADABLE SOLVENTS FOR THE CHEMICAL INDUSTRY | TIMM9, B2M, TIMM44 | RECQL 3900/4885GLA 2779/4885HPGD 409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.